Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Baxter Board Adds Boston Scientific CEO to its Ranks - Medical Product Outsourcing
Columns

Baxter Board Adds Boston Scientific CEO to its Ranks

Deerfield, Ill.-based Baxter International Inc. has invited Boston Scientific Corp. CEO Mike Mahoney to its board, adding a director who turned around one of the nation’s biggest medical device companies.

Mahoney joins Baxter’s board during a time of transition for the company. Baxter CEO Robert Parkinson announced his plans to step down earlier this year after spending more than a decade there. Mahoney’s nomination was encouraged by Third Point LLC, Baxter’s biggest shareholder, which played a role in recruiting him, according to a person familiar with the deliberations who declined to be identified discussing non-public information. Third Point wants Baxter to replicate Mahoney’s track record at Marlborough, Mass.-based Boston Scientific, where he returned the company to growth after a four-year losing streak, boosted operating margins and shifted into faster-growing product areas. The device behemoth’s Q3 operational revenue swelled 9 percent to $1.88 billion, and adjusted earnings per share surged 20 percent to 24 cents.

Mahoney joins Third Point partner Munib Islam on Baxter’s board and fulfills the company’s Sept. 30 agreement to appoint a second independent director to the group.

“It adds some credibility to the board in terms of expertise in medtech for the CEO succession planning,” said Jonathan Palmer, an analyst at Bloomberg Intelligence in New York. The companies have very little product overlap since Baxter focuses on hospital products and Boston Scientific on cardiovascular and other implantable devices, he said.

Baxter primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters